Jago Grahak Jago

Jago Grahak Jago Logo

March 2024

Gene therapy maker, Bluebird to revise financials after accounting errors

Mar 27,2024 London: Gene therapy maker bluebird bio said on Tuesday it plans to revise its financial statements for 2022 and the first three quarters of last year due to accounting errors related to some contract manufacturing agreements. The company said it has identified “material weakness in its internal control over financial reporting”, and will […]

Gene therapy maker, Bluebird to revise financials after accounting errors Read More »

US FDA approves Merck’s Winrevair for treatment of adults with pulmonary arterial hypertension

Mar 28,2024 Merck, known as MSD outside of the United States and Canada, announced that the US Food and Drug Administration (FDA) has approved sotatercept-csrk (US Brand Name: Winrevair, for injection, 45mg, 60mg) for the treatment of adults with pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1) to increase exercise capacity, improve WHO

US FDA approves Merck’s Winrevair for treatment of adults with pulmonary arterial hypertension Read More »

Medanta flags Trehan AI deepfake on obesity drug

Mar 20,2024 Gurgaon: Medanta Hospital on Tuesday filed a complaint alleging that a “deepfake” video that features its chairperson and managing director Dr Naresh Trehan endorsing a weight loss drug is circulating on social media. DCP (cybercrime) Siddhant Jain said an FIR was registered at the Cyber East police station against unidentified accused under sections

Medanta flags Trehan AI deepfake on obesity drug Read More »

How’s the IT health? Not good, sir, as 61% have high cholesterol, says study

Mar 25,2024 New Delhi: About 77% of the 56,000 IT sector corporate employees in the age group of 25-40 years suffers from deranged values in several health parameters and 61% have high cholesterol, a clinical study conducted by HCL Healthcare has revealed. The study was conducted on people working in the sector who underwent health

How’s the IT health? Not good, sir, as 61% have high cholesterol, says study Read More »

Ensure no beverage is sold as ‘health drink’: NCPCR

Mar 19,2024 New Delhi: Noting that there was no mention of ‘health drink’ in the Food Safety and Standards Act 2006 , the National Commission for Protection of Child Rights has written to the department of consumer affairs of all states and Union Territories recommending that “no drink, beverages including Bournvita and other similar products

Ensure no beverage is sold as ‘health drink’: NCPCR Read More »

DCGI directs SLAs to cancel product permission to antibiotic combo of meropenem & disodium EDTA for injection

Mar 13,2024 The Drugs Controller General (India) (DCGI) has directed the state drug regulators in the country to cancel the product permission granted by them for manufacturing and marketing of certain antibiotic drug combination meropenem and disodium EDTA for injection since it is a new drug and needs approval from the Centre also. DCGI Dr

DCGI directs SLAs to cancel product permission to antibiotic combo of meropenem & disodium EDTA for injection Read More »

EU drug regulator does not refer to Eisai-Biogen Alzheimer’s drug in meeting notes

Mar 22,2024 London: The European Union’s medicines regulator did not mention Eisai and Biogen’s Alzheimer’s drug in its notes and recommendations on Friday. The European Medicines Agency had said it would hold a oral hearing to discuss the drug, lecanemab, this week. The drug, sold as Leqembi in the United States has been under review

EU drug regulator does not refer to Eisai-Biogen Alzheimer’s drug in meeting notes Read More »

ENTOD develops human insulin eye drops to treat corneal conditions

Mar 19,2024 New Delhi: ENTOD Pharmaceuticals on Tuesday announced the developement of human insulin eye drops designed to treat corneal eye conditions like neurotrophic corneal ulcers and dry eyes. Although Insulin has traditionally been administered through injections to manage blood sugar levels in diabetic patients globally, recent research from various global studies and literature searches

ENTOD develops human insulin eye drops to treat corneal conditions Read More »

Sanofi & Cipla partner to boost CNS portfolio in India

Mar 27,2024 Mumbai, March 26, 2024. An exclusive distribution and marketing agreement was today announced between Sanofi India and Cipla for Sanofi’s Central Nervous System (CNS) product line in India. As part of this collaboration, Cipla will handle the distribution of Sanofi India’s six CNS brands, which include the industry-leading Frisium® brand of anti-epileptic drugs.

Sanofi & Cipla partner to boost CNS portfolio in India Read More »